Michael G. McDonell, PhD; Katherine A. Hirchak, PhD; Jalene Herron, MS; et al.
free access
JAMA Psychiatry. 2021;78(6):599-606. doi:10.1001/jamapsychiatry.2020.4768
This randomized clinical trial examines whether a culturally tailored contingency management intervention, in which incentives are offered for laboratory-confirmed alcohol abstinence, results in increased alcohol abstinence among adults in 3 American Indian and Alaska Native communities.
Miriam K. Depping, PhD; Natalie Uhlenbusch, MSc; Martin Härter, MD, PhD; et al.
free access
JAMA Psychiatry. 2021;78(6):607-615. doi:10.1001/jamapsychiatry.2020.4783
This randomized clinical trial evaluates the efficacy of a brief, transdiagnostic, peer-delivered intervention for patients with rare diseases in addition to care as usual compared with care as usual only.
Maninder K. Kahlon, PhD; Nazan Aksan, PhD; Rhonda Aubrey, MHI; et al.
open access
JAMA Psychiatry. 2021;78(6):616-622. doi:10.1001/jamapsychiatry.2021.0113
This randomized clinical trial examines whether a layperson-delivered, empathy-focused program of telephone calls could rapidly improve loneliness, depression, and anxiety in at-risk adults.
Solal Chauquet, MSc; Zhihong Zhu, PhD; Michael C. O鈥橠onovan, MD, PhD; et al.
free access
JAMA Psychiatry. 2021;78(6):623-631. doi:10.1001/jamapsychiatry.2021.0005
This genetic association and mendelian randomization study estimates the potential effect of different antihypertensive drug classes on schizophrenia, bipolar disorder, and major depressive disorder.
T. Scott Stroup, MD, MPH; Mark Olfson, MD, MPH; Cecilia Huang, PhD; et al.
free access
JAMA Psychiatry. 2021;78(6):632-641. doi:10.1001/jamapsychiatry.2021.0042
This cohort study estimates the age-specific incidence and prevalence of dementia diagnoses among older US adults with schizophrenia compared with those in a group without serious mental illness.
Eric L. Ross, MD; Kelly L. Zuromski, PhD; Ben Y. Reis, PhD; et al.
free access
JAMA Psychiatry. 2021;78(6):642-650. doi:10.1001/jamapsychiatry.2021.0089
This economic evaluation identifies threshold values of sensitivity, specificity, and positive predictive value that a suicide risk prediction model must attain for cost-effective use of a suicide risk reduction intervention for high-risk individuals.
Matthew A. Davis, MPH, PhD; Benjamin A. Y. Cher, MS; Christopher R. Friese, RN, PhD; et al.
free access
has audio
JAMA Psychiatry. 2021;78(6):651-658. doi:10.1001/jamapsychiatry.2021.0154
This cohort study estimates the national incidence of suicide among nurses and examines characteristics of nurse suicides compared with physicians and the general population.
-
Podcast:
Suicide Risk Among US Nurses and Physicians
Mia Maria Günak, MSc; Deborah E. Barnes, PhD, MPH; Kristine Yaffe, MD; et al.
free access
JAMA Psychiatry. 2021;78(6):659-666. doi:10.1001/jamapsychiatry.2021.0150
This cohort study examines the association between diagnoses of mild cognitive impairment or dementia and suicide attempt, explores potential psychiatric moderators, and assesses whether the association differs based on recency of diagnosis in 5 US databases.
Kate Merritt, PhD; Philip K. McGuire, FMedSci; Alice Egerton, PhD; et al.
open access
JAMA Psychiatry. 2021;78(6):667-681. doi:10.1001/jamapsychiatry.2021.0380
This mega-analysis assesses whether age, symptom severity, level of functioning, and antipsychotic treatment are associated with glutamate or glutamatergic metabolite levels measured with proton magnetic resonance spectroscopy in the medial frontal cortex or medial temporal lobe of patients with schizophrenia.